Ngā hua rapu kaituhi

1

Small-Molecule Antagonists of p53-MDM2 Binding: Research Tools and Potential Therapeutics mā Lyubomir T. Vassilev

I whakaputaina 2004

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
2

Cell Cycle Synchronization at the G<sub>2</sub>/M Phase Border by Reversible Inhibition of CDK1 mā Lyubomir T. Vassilev

I whakaputaina 2006

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
3

Targeting the p53–MDM2 interaction to treat cancer mā Christian Klein, Lyubomir T. Vassilev

I whakaputaina 2004

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
4

An initiation zone of chromosomal DNA replication located upstream of the c-myc gene in proliferating HeLa cells. mā Lyubomir T. Vassilev, Edward M. Johnson

I whakaputaina 1990

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
5

Mapping initiation sites of DNA replication<i>in vivo</i>using polymerase chain reaction amplification of nascent strand segments mā Lyubomir T. Vassilev, Edward M. Johnson

I whakaputaina 1989

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

p21 does not protect cancer cells from apoptosis induced by nongenotoxic p53 activation mā Mingxuan Xia, Dejan Knezevic, Lyubomir T. Vassilev

I whakaputaina 2010

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
7

Mapping an origin of DNA replication at a single-copy locus in exponentially proliferating mammalian cells. mā Lyubomir T. Vassilev, William C. Burhans, Melvin L. DePamphilis

I whakaputaina 1990

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
8

Selective ATM inhibition augments radiation-induced inflammatory signaling and cancer cell death mā Li-Ya Chiu, Qing Sun, Frank T. Zenke, Andree Blaukat, Lyubomir T. Vassilev

I whakaputaina 2023

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
9

Differentiation of trophoblast stem cells into giant cells is triggered by p57/Kip2 inhibition of CDK1 activity mā Zakir Ullah, Matthew J. Kohn, Rieko Yagi, Lyubomir T. Vassilev, Melvin L. DePamphilis

I whakaputaina 2008

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
10

Induction of p53-Dependent Senescence by the MDM2 Antagonist Nutlin-3a in Mouse Cells of Fibroblast Origin mā Alejo Efeyan, Ana Ortega-Molina, Susana Velasco-Miguel, Daniel Herranz, Lyubomir T. Vassilev, Manuel Serrano

I whakaputaina 2007

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
11

Emetine allows identification of origins of mammalian DNA replication by imbalanced DNA synthesis, not through conservative nucleosome segregation. mā William C. Burhans, Lyubomir T. Vassilev, Jiarui Wu, José M. Sogo, Ferez S. Nallaseth, Melvin L. DePamphilis

I whakaputaina 1991

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
12

Selective small-molecule inhibitor reveals critical mitotic functions of human CDK1 mā Lyubomir T. Vassilev, Christian Tovar, Shaoqing Chen, Dejan Knezevic, Xiaolan Zhao, Hongmao Sun, David Heimbrook, Li Chen

I whakaputaina 2006

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
13

MDM2 antagonist Nutlin-3a potentiates antitumour activity of cytotoxic drugs in sarcoma cell lines mā Hege O. Ohnstad, Erik B. Paulsen, Paul Noordhuis, Marianne Berg, Ragnhild A. Lothe, Lyubomir T. Vassilev, Ola Myklebost

I whakaputaina 2011

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
14

Therapeutic Implications of p53 Status on Cancer Cell Fate Following Exposure to Ionizing Radiation and the DNA-PK Inhibitor M3814 mā Qing Sun, Yige Guo, Xiaohong Liu, Frank Czauderna, Michael I. Carr, Frank T. Zenke, Andree Blaukat, Lyubomir T. Vassilev

I whakaputaina 2019

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
15

Triptolide sensitizes AML cells to TRAIL-induced apoptosis via decrease of XIAP and p53-mediated increase of DR5 mā Bing Z. Carter, Duncan H. Mak, Wendy Schober, Martin Dietrich, Clemencia Pinilla, Lyubomir T. Vassilev, John C. Reed, Michael Andreeff

I whakaputaina 2008

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
16

Simultaneous activation of p53 and inhibition of XIAP enhance the activation of apoptosis signaling pathways in AML mā Bing Z. Carter, Duncan H. Mak, Wendy Schober, Erich Koller, Clemencia Pinilla, Lyubomir T. Vassilev, John C. Reed, Michael Andreeff

I whakaputaina 2009

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
17

Phosphorylation of p53 on Key Serines Is Dispensable for Transcriptional Activation and Apoptosis mā Thelma Thompson, Christian Tovar, Hong Yang, Daisy Carvajal, Binh Thanh Vu, Qunli Xu, Geoffrey M. Wahl, David Heimbrook, Lyubomir T. Vassilev

I whakaputaina 2004

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
18

Depletion of Mutant p53 and Cytotoxicity of Histone Deacetylase Inhibitors mā Mikhail V. Blagosklonny, Shana Y. Trostel, Ganesh Kayastha, Zoya N. Demidenko, Lyubomir T. Vassilev, Larisa Y. Romanova, Susan E. Bates, Tito Fojo

I whakaputaina 2005

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
19

A New Class of Selective ATM Inhibitors as Combination Partners of DNA Double-Strand Break Inducing Cancer Therapies mā Astrid Zimmermann, Frank T. Zenke, Li-Ya Chiu, Heike Dahmen, Ulrich Pehl, Thomas Fuchß, Thomas Grombacher, Beatrix Blume, Lyubomir T. Vassilev, Andree Blaukat

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
20

Pharmacologic Inhibitor of DNA-PK, M3814, Potentiates Radiotherapy and Regresses Human Tumors in Mouse Models mā Frank T. Zenke, Astrid Zimmermann, Christian Sirrenberg, Heike Dahmen, Vladimir Kirkin, Ulrich Pehl, Thomas Grombacher, Claudia Wilm, Thomas Fuchß, Christiane Amendt, Lyubomir T. Vassilev, Andree Blaukat

I whakaputaina 2020

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:

Ngā hua rapu - Lyubomir T. Vassilev

Small-Molecule Antagonists of p53-MDM2 Binding: Research Tools and Potential Therapeutics mā Lyubomir T. Vassilev

Cell Cycle Synchronization at the G<sub>2</sub>/M Phase Border by Reversible Inhibition of CDK1 mā Lyubomir T. Vassilev

Targeting the p53–MDM2 interaction to treat cancer mā Christian Klein, Lyubomir T. Vassilev

An initiation zone of chromosomal DNA replication located upstream of the c-myc gene in proliferating HeLa cells. mā Lyubomir T. Vassilev, Edward M. Johnson

Mapping initiation sites of DNA replication<i>in vivo</i>using polymerase chain reaction amplification of nascent strand segments mā Lyubomir T. Vassilev, Edward M. Johnson

p21 does not protect cancer cells from apoptosis induced by nongenotoxic p53 activation mā Mingxuan Xia, Dejan Knezevic, Lyubomir T. Vassilev

Mapping an origin of DNA replication at a single-copy locus in exponentially proliferating mammalian cells. mā Lyubomir T. Vassilev, William C. Burhans, Melvin L. DePamphilis

Selective ATM inhibition augments radiation-induced inflammatory signaling and cancer cell death mā Li-Ya Chiu, Qing Sun, Frank T. Zenke, Andree Blaukat, Lyubomir T. Vassilev

Differentiation of trophoblast stem cells into giant cells is triggered by p57/Kip2 inhibition of CDK1 activity mā Zakir Ullah, Matthew J. Kohn, Rieko Yagi, Lyubomir T. Vassilev, Melvin L. DePamphilis

Induction of p53-Dependent Senescence by the MDM2 Antagonist Nutlin-3a in Mouse Cells of Fibroblast Origin mā Alejo Efeyan, Ana Ortega-Molina, Susana Velasco-Miguel, Daniel Herranz, Lyubomir T. Vassilev, Manuel Serrano

Emetine allows identification of origins of mammalian DNA replication by imbalanced DNA synthesis, not through conservative nucleosome segregation. mā William C. Burhans, Lyubomir T. Vassilev, Jiarui Wu, José M. Sogo, Ferez S. Nallaseth, Melvin L. DePamphilis

Selective small-molecule inhibitor reveals critical mitotic functions of human CDK1 mā Lyubomir T. Vassilev, Christian Tovar, Shaoqing Chen, Dejan Knezevic, Xiaolan Zhao, Hongmao Sun, David Heimbrook, Li Chen

MDM2 antagonist Nutlin-3a potentiates antitumour activity of cytotoxic drugs in sarcoma cell lines mā Hege O. Ohnstad, Erik B. Paulsen, Paul Noordhuis, Marianne Berg, Ragnhild A. Lothe, Lyubomir T. Vassilev, Ola Myklebost

Therapeutic Implications of p53 Status on Cancer Cell Fate Following Exposure to Ionizing Radiation and the DNA-PK Inhibitor M3814 mā Qing Sun, Yige Guo, Xiaohong Liu, Frank Czauderna, Michael I. Carr, Frank T. Zenke, Andree Blaukat, Lyubomir T. Vassilev

Triptolide sensitizes AML cells to TRAIL-induced apoptosis via decrease of XIAP and p53-mediated increase of DR5 mā Bing Z. Carter, Duncan H. Mak, Wendy Schober, Martin Dietrich, Clemencia Pinilla, Lyubomir T. Vassilev, John C. Reed, Michael Andreeff

Simultaneous activation of p53 and inhibition of XIAP enhance the activation of apoptosis signaling pathways in AML mā Bing Z. Carter, Duncan H. Mak, Wendy Schober, Erich Koller, Clemencia Pinilla, Lyubomir T. Vassilev, John C. Reed, Michael Andreeff

Phosphorylation of p53 on Key Serines Is Dispensable for Transcriptional Activation and Apoptosis mā Thelma Thompson, Christian Tovar, Hong Yang, Daisy Carvajal, Binh Thanh Vu, Qunli Xu, Geoffrey M. Wahl, David Heimbrook, Lyubomir T. Vassilev

Depletion of Mutant p53 and Cytotoxicity of Histone Deacetylase Inhibitors mā Mikhail V. Blagosklonny, Shana Y. Trostel, Ganesh Kayastha, Zoya N. Demidenko, Lyubomir T. Vassilev, Larisa Y. Romanova, Susan E. Bates, Tito Fojo

A New Class of Selective ATM Inhibitors as Combination Partners of DNA Double-Strand Break Inducing Cancer Therapies mā Astrid Zimmermann, Frank T. Zenke, Li-Ya Chiu, Heike Dahmen, Ulrich Pehl, Thomas Fuchß, Thomas Grombacher, Beatrix Blume, Lyubomir T. Vassilev, Andree Blaukat

Ngā utauta rapu:

Ngā marau whai pānga